Is penicillin and cefazolin (Ancef) safe to administer during the first trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, both penicillin and cefazolin (Ancef) are safe to administer during the first trimester of pregnancy.

Both penicillin and cefazolin are considered safe and appropriate antibiotics for use throughout pregnancy, including the first trimester, with extensive clinical experience supporting their safety profile.

Evidence Supporting Safety

Penicillin in First Trimester

The evidence consistently demonstrates penicillin's safety during early pregnancy:

  • Penicillin is classified as compatible for use during pre-conception and first trimester (T1) according to respiratory disease management guidelines 1
  • CDC guidelines extensively recommend penicillin G and ampicillin for intrapartum prophylaxis, with decades of safe use documented 2
  • Penicillin has been the standard treatment for syphilis during pregnancy for decades, with clear recommendations to use penicillin regimens appropriate for the stage of disease throughout all trimesters 3
  • All penicillins are considered low-risk in pregnancy with no teratogenic effects documented in animal or human studies 1

Cefazolin (Ancef) in First Trimester

Cefazolin has robust safety data for pregnancy:

  • FDA labeling states that reproduction studies in rats, mice, and rabbits at doses up to 25 times the human dose revealed no evidence of impaired fertility or harm to the fetus 4
  • The FDA label notes that "the drug appears to have no adverse effect on the fetus" when administered prior to cesarean section 4
  • A large population-based case-control study of 22,865 pregnant women found no detectable teratogenic risk from cephalosporin treatment during pregnancy, including during the critical second and third months of gestation 5
  • Cefazolin crosses the placental barrier even in the first trimester, though at lower concentrations than later trimesters, with distribution limited to body fluids 6, 7
  • Most cephalosporin studies found these antibiotics to be safe for use in pregnancy 1

Clinical Recommendations

When to Use These Antibiotics

Penicillin indications:

  • Group B Streptococcus (GBS) prophylaxis: Penicillin G is the preferred agent (5 million units IV initial dose, then 2.5-3.0 million units every 4 hours) 2
  • Syphilis treatment: Penicillin regimens appropriate for disease stage should be used throughout pregnancy 3
  • General bacterial infections susceptible to penicillin

Cefazolin indications:

  • Surgical prophylaxis (including cesarean delivery): 2g IV initial dose, then 1g IV every 8 hours 2
  • Alternative for non-anaphylactic penicillin-allergic patients
  • Bacterial infections requiring cephalosporin coverage

Important Caveats

For penicillin:

  • No alternatives exist for treating syphilis in pregnancy—penicillin-allergic patients should be desensitized 3
  • Narrow spectrum makes it preferable to ampicillin when appropriate 8

For cefazolin:

  • While animal studies show safety, the FDA label notes "there are no adequate and well-controlled studies in pregnant women" and recommends use "only if clearly needed" 4
  • This conservative FDA language is standard despite extensive clinical experience showing safety
  • Recent evidence shows cefazolin is safe even in pregnant patients with documented penicillin anaphylaxis (only 1.1% experienced mild reactions, no anaphylaxis) 9
  • Should be avoided only in patients with severe delayed hypersensitivity reactions (Stevens-Johnson syndrome, hepatitis, nephritis) to penicillin 10

Pharmacokinetic Considerations

During pregnancy, particularly in second and third trimesters:

  • Volume of distribution increases 9.2-18.4%
  • Clearance increases 30.8-100%
  • This may necessitate dosing adjustments later in pregnancy, though standard dosing is appropriate for first trimester 11

Bottom Line

Both medications have decades of safe use in pregnancy with no evidence of teratogenicity or fetal harm. The theoretical concerns about lack of controlled human studies should not prevent their use when clinically indicated, as the extensive observational data and clinical experience strongly support their safety profile throughout all trimesters of pregnancy.

References

Research

Transplacental passage of cefazolin in the first trimester of pregnancy.

European journal of obstetrics, gynecology, and reproductive biology, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.